<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A wealth of evidence has demonstrated that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning induces brain ischemic tolerance, but the mechanism remains poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>This study was designed to investigate the role of canonical Notch signaling in the neuroprotection induced by <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning in a mouse model </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: C57BL/6 mice were pretreated with 1-h <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> exposure at a dose of 2.5% for 5 consecutive days </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-four hours after the last exposure, <z:hpo ids='HP_0000001'>all</z:hpo> mice were subjected to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 60 min </plain></SENT>
<SENT sid="4" pm="."><plain>Neurobehavioral scores, brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes, and cellular <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were determined at 72 h after reperfusion (n = 10 per group) </plain></SENT>
<SENT sid="5" pm="."><plain>The activation of Notch signaling was evaluated (n = 5 per group), and its role in ischemic tolerance was assessed by intraperitoneal administration of Î³-secretase inhibitor DAPT (100 mg/kg, n = 10 per group) and conditional Notch-RBP-J knockout technique (n = 8 per group) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes (42.5%), improved neurologic outcomes (P &lt; 0.01 vs. control), and attenuated neuronal cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (cells positive for terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="16450">2'-deoxyuridine</z:chebi> 5'-<z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi> nick-end labeling reduced to 21.2%) </plain></SENT>
<SENT sid="7" pm="."><plain>The expression of Notch1 intracellular domain (1.35 folds) and the transcriptions of Hes1 (1.95 times) and Hes5 (1.48 times) were up-regulated </plain></SENT>
<SENT sid="8" pm="."><plain>DAPT augmented the brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> (1.64-fold) and decreased neurologic scores (P = 0.43 vs. <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>) in <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>-preconditioned mice </plain></SENT>
<SENT sid="9" pm="."><plain>Brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes, neurobehavioral scores, and apoptotic cell numbers showed no significance between Notch knockout mice with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning and <z:mp ids='MP_0002169'>wild-type</z:mp> mice without preconditioning </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning-induced protective effects against transient cerebral ischemic injuries are mediated by the activation of canonical Notch signaling pathway in mice </plain></SENT>
</text></document>